Loading...
Loading...
Tenet Healthcare Corporation THC reported better-than-expected second-quarter earnings late Wednesday but gave weak guidance.
- Q2 sales increased 36% YY to $4.9 billion, beating the consensus estimate of $4.8 billion.
- Adjusted EPS came in at $1.59, higher than $1.26 a year ago and ahead of the Wall Street estimate of $1.07.
- Adjusted EBITDA was $834 million than $732 million last year quarter.
- Net operating revenues in the Hospital segment were $4.1 billion in Q2'21, a growth of 32.6% Y/Y, primarily due to significantly higher volumes given the impact of the pandemic in Q2'20, as well as higher patient acuity and pricing yield.
- Same-hospital net patient service revenues were $3.7 billion, +33.1%.
- Same-hospital adjusted admissions increased 23.9% Y/Y; same-hospital net patient service revenue per adjusted admission up 7.4%. Same-facility system-wide ambulatory surgical cases up 68.2% Y/Y.
- Outlook: Tenet sees full-year EPS of $5.23-$5.73 vs. $4.16-$5.46 previously. The new $5.48 midpoint is above the consensus for $5.00, but that includes Q2's $0.50 beat.
- It sees sales of $19.25 billion $19.65 billion. Its new revenue midpoint of $19.45 billion is below the consensus of $19.61 billion.
- The hospital operator sees Q3 adjusted EPS of $0.73 - $1.06 on revenue of $4.6 billion - $4.8 billion.
- Hospital stocks have been in good health, fueled by blowout HCA Healthcare earnings early Tuesday.
- Price Action: THC shares are down 3.1% at $70.00 during the premarket session on the last check Thursday.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in